Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2016—2020
Quinn T. Ostrom, Mackenzie Price, Corey Neff, et al.
Neuro-Oncology (2023) Vol. 25, Iss. Supplement_4, pp. iv1-iv99
Open Access | Times Cited: 605

Showing 1-25 of 605 citing articles:

Mechanisms of temozolomide resistance in glioblastoma - a comprehensive review
Neha Singh, Alexandra Miner, Lauren Hennis, et al.
Cancer Drug Resistance (2020)
Open Access | Times Cited: 274
Glioma stem cells and their roles within the hypoxic tumor microenvironment
Nathaniel Boyd, Anh Tran, Joshua D. Bernstock, et al.
Theranostics (2020) Vol. 11, Iss. 2, pp. 665-683
Open Access | Times Cited: 155
Glioma
Michael Weller, Patrick Y. Wen, Susan M. Chang, et al.
Nature Reviews Disease Primers (2024) Vol. 10, Iss. 1
Closed Access | Times Cited: 111
Signaling pathways and therapeutic approaches in glioblastoma multiforme (Review)
Marsel Khabibov, Айрат Гарифуллин, Yanis Boumber, et al.
International Journal of Oncology (2022) Vol. 60, Iss. 6
Open Access | Times Cited: 75
2021 updates to the World Health Organization classification of adult-type and pediatric-type diffuse gliomas: a clinical practice review
Diana Thomas
Chinese Clinical Oncology (2023) Vol. 12, Iss. 1, pp. 7-7
Open Access | Times Cited: 57
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2017–2021
Mackenzie Price, Christine Ann Pittman Ballard, Julia Benedetti, et al.
Neuro-Oncology (2024) Vol. 26, Iss. Supplement_6, pp. vi1-vi85
Open Access | Times Cited: 31
Glioblastoma: An Update in Pathology, Molecular Mechanisms and Biomarkers
Zhong Lan, Xin Li, Xiao-Qin Zhang
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 3040-3040
Open Access | Times Cited: 30
Meningioma: International Consortium on Meningiomas consensus review on scientific advances and treatment paradigms for clinicians, researchers, and patients
Justin Z. Wang, Alexander Landry, David R. Raleigh, et al.
Neuro-Oncology (2024) Vol. 26, Iss. 10, pp. 1742-1780
Open Access | Times Cited: 25
CBTRUS Statistical Report: American Brain Tumor Association & NCI Neuro-Oncology Branch Adolescent and Young Adult Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2016–2020
Mackenzie Price, Corey Neff, Nitin Nagarajan, et al.
Neuro-Oncology (2024) Vol. 26, Iss. Supplement_3, pp. iii1-iii53
Closed Access | Times Cited: 21
Receptor Ligand-Free Mesoporous Silica Nanoparticles: A Streamlined Strategy for Targeted Drug Delivery across the Blood–Brain Barrier
Zih-An Chen, C.‐H. Wu, Si‐Han Wu, et al.
ACS Nano (2024) Vol. 18, Iss. 20, pp. 12716-12736
Open Access | Times Cited: 20
The oncological role of resection in newly diagnosed diffuse adult-type glioma defined by the WHO 2021 classification: a Review by the RANO resect group
Philipp Karschnia, Jasper Kees Wim Gerritsen, Nico Teske, et al.
The Lancet Oncology (2024) Vol. 25, Iss. 9, pp. e404-e419
Open Access | Times Cited: 17
State-of-the-art of microbubble-assisted blood-brain barrier disruption
Kang-Ho Song, Brandon K. Harvey, Mark A. Borden
Theranostics (2018) Vol. 8, Iss. 16, pp. 4393-4408
Open Access | Times Cited: 149
Clinical management and survival outcomes of patients with different molecular subtypes of diffuse gliomas in China (2011–2017): a multicenter retrospective study from CGGA
Kenan Zhang, Xing Liu, Guanzhang Li, et al.
Cancer Biology and Medicine (2022) Vol. 19, Iss. 10, pp. 1460-1476
Open Access | Times Cited: 49
Chitinase-3 like-protein-1 promotes glioma progression via the NF-κB signaling pathway and tumor microenvironment reprogramming
Ting Zhao, Jianming Zeng, Yujie Xu, et al.
Theranostics (2022) Vol. 12, Iss. 16, pp. 6989-7008
Open Access | Times Cited: 46
A Review of Approaches to Potentiate the Activity of Temozolomide against Glioblastoma to Overcome Resistance
Aniruddha S. Karve, Janki Desai, Sidharth Nitin Gadgil, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 6, pp. 3217-3217
Open Access | Times Cited: 14
Extensive Shrinkage and Long-term Stable Disease in a Teenage Female Patient With High-grade Glioma Treated With Temozolomide and Radiation in Combination With Oral Recombinant Methioninase and a Low-methionine Diet
MOTOKAZU SATO, Qinghong Han, KOHEI MIZUTA, et al.
In Vivo (2024) Vol. 38, Iss. 3, pp. 1459-1464
Open Access | Times Cited: 13
Association between gut microbiota and glioblastoma: a Mendelian randomization study
Song Wang, Fangxu Yin, Zheng Guo, et al.
Frontiers in Genetics (2024) Vol. 14
Open Access | Times Cited: 12
Advances in Neuro-Oncological Imaging: An Update on Diagnostic Approach to Brain Tumors
Paniz Sabeghi, P Zaránd, Sina Zargham, et al.
Cancers (2024) Vol. 16, Iss. 3, pp. 576-576
Open Access | Times Cited: 11
Beyond fluorescence-guided resection: 5-ALA-based glioblastoma therapies
Walter Stummer, Michael Müther, Dorothee Cäcilia Spille
Acta Neurochirurgica (2024) Vol. 166, Iss. 1
Open Access | Times Cited: 11
A systematic review of immunotherapy in high-grade glioma: learning from the past to shape future perspectives
Giacomo Sferruzza, Stefano Consoli, Fedele Dono, et al.
Neurological Sciences (2024) Vol. 45, Iss. 6, pp. 2561-2578
Closed Access | Times Cited: 9
Genetic and epigenetic instability as an underlying driver of progression and aggressive behavior in IDH-mutant astrocytoma
Timothy E. Richardson, Jamie M. Walker, Dolores Hambardzumyan, et al.
Acta Neuropathologica (2024) Vol. 148, Iss. 1
Open Access | Times Cited: 9
Updated Response Assessment in Neuro-Oncology (RANO) for Gliomas
Gilbert Youssef, Patrick Y. Wen
Current Neurology and Neuroscience Reports (2024) Vol. 24, Iss. 2, pp. 17-25
Closed Access | Times Cited: 8
CYP3A5 promotes glioblastoma stemness and chemoresistance through fine-tuning NAD+/NADH ratio
Wentao Hu, Xing Cui, Hongyu Liu, et al.
Journal of Experimental & Clinical Cancer Research (2025) Vol. 44, Iss. 1
Open Access | Times Cited: 1
Development and validation of a molecular classifier of meningiomas
Alexander Landry, Justin Z. Wang, Jeff Liu, et al.
Neuro-Oncology (2025)
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top